Results 141 to 150 of about 3,036,806 (196)
Disseminated Erythema and Vesicles on the Trunk and Extremities in a Teenager: A Quiz. [PDF]
Acta Derm VenereolZhao C, Wang H, Wang L.
europepmc +1 more source
Bullous Systemic Lupus Erythematosus as a Marker of Treatment-Refractory Systemic Disease: A Case Report. [PDF]
CureusIzadian Bidgoli A +5 more
europepmc +1 more source
Bullous Systemic Lupus Erythematosus As the Initial Presentation of Systemic Lupus Erythematosus. [PDF]
CureusKydyralieva C.
europepmc +1 more source
Bullous Pemphigoid in Children: Sustained 8-Year Remission After Short-Course Corticosteroid Therapy. [PDF]
Clin Case RepWang F, Li H, Xu Y, Wang W.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis
Experimental Dermatology, 2010Please cite this paper as: IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis. Experimental Dermatology 2010; 19: 648–653.Background: Patients with bullous pemphigoid (BP), mucous membrane pemphigoid (MMP) and pemphigoid gestationis (PG) have IgG antibodies against BP180 and BP230, components of the hemidesmosomes.
Barbara, Horváth +6 more
openaire +4 more sources
Clinics in Dermatology, 2001
Linear immunoglobulin A (IgA) disease, also known as linear IgA bullous dermatosis (LAD), is a rare acquired subepidermal blistering disease characterized by continuous linear IgA deposits in the basement membrane zone (BMZ) when visualized on direct immunofluorescence microscopy (DIF). Linear IgA bullous dermatosis was first described in 1901 by Bowen,
S V, Guide, M P, Marinkovich
openaire +4 more sources
Linear immunoglobulin A (IgA) disease, also known as linear IgA bullous dermatosis (LAD), is a rare acquired subepidermal blistering disease characterized by continuous linear IgA deposits in the basement membrane zone (BMZ) when visualized on direct immunofluorescence microscopy (DIF). Linear IgA bullous dermatosis was first described in 1901 by Bowen,
S V, Guide, M P, Marinkovich
openaire +4 more sources
New England Journal of Medicine, 2020
Linear IgA Bullous Dermatosis A 5-year-old boy presented with a 2-week history of painless blisters localized to the scrotum. Biopsy confirmed a diagnosis of linear IgA bullous dermatosis.
Cristina, Vico-Alonso +1 more
openaire +2 more sources
Linear IgA Bullous Dermatosis A 5-year-old boy presented with a 2-week history of painless blisters localized to the scrotum. Biopsy confirmed a diagnosis of linear IgA bullous dermatosis.
Cristina, Vico-Alonso +1 more
openaire +2 more sources
Symblepharon in Linear IgA Bullous Dermatosis
New England Journal of Medicine, 2021Symblepharon in Linear IgA Bullous Dermatosis A 73-year-old man presented to the eye clinic with blurred vision, photophobia, and a rash. Eye examination showed symblepharon.
Jonathan C. Tsui, Spencer Onishi
openaire +2 more sources
International Journal of Dermatology, 1999
Linear IgA bullous dermatosis (LABD) is a unique autoimmune blistering disease which can present both in children and adults. There are various clinical presentations of the disease which can involve both cutaneous and mucosal tissues. LABD has been reported to be associated with medications, ulcerative colitis, and malignancies.
Conleth A. Egan +3 more
openaire +2 more sources
Linear IgA bullous dermatosis (LABD) is a unique autoimmune blistering disease which can present both in children and adults. There are various clinical presentations of the disease which can involve both cutaneous and mucosal tissues. LABD has been reported to be associated with medications, ulcerative colitis, and malignancies.
Conleth A. Egan +3 more
openaire +2 more sources
Refractory linear IgA bullous dermatosis successfully treated with mycophenolate sodium
Journal of Dermatological Treatment, 2008 Linear IgA bullous dermatosis (LABD) is a rare, blistering autoimmune disease characterized by linear deposits of IgA at the basement membrane zone (BMZ), with the possible presence of circulating IgA anti-BMZ antibodies.
Emilio Berti +2 more
exaly +2 more sources